| |
| |
|
| Insider
Information: |
Schwartz Brian |
| Relationship: |
|
| City: |
Boston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
77,124 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$14,525 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
77,124 |
|
|
| Total
Value |
$14,525 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alaunos Therapeutics |
TCRT |
Officer |
2008-03-26 |
25,000 |
|
0 |
Premium* |
|
|
Arqule Inc |
ARQL |
See Remarks |
2020-01-16 |
0 |
2008-12-05 |
0 |
Premium* |
|
|
Vincerx Pharma, Inc |
VINC |
Director |
2020-03-05 |
6,000 |
|
0 |
Premium* |
|
|
Cyclacel Pharmaceuticals Inc |
CYCC |
Interim Chief Medical ... |
2024-01-29 |
15,205 |
2021-06-15 |
0 |
Premium* |
|
|
Infinity Pharmaceuticals Inc |
INFI |
|
2022-06-16 |
30,919 |
2022-06-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
24 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CYCC |
Cyclacel Pharmaceuticals ... |
Interim Chief Medical Officer |
• • – |
2024-01-29 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
15,205 |
0 |
- |
|
| CYCC |
Cyclacel Pharmaceuticals ... |
Director |
– • – |
2023-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
21,219 |
40,602 |
0 |
- |
|
| INFI |
Infinity Pharmaceuticals ... |
|
• • – |
2022-06-16 |
4 |
A |
$0.68 |
$20,994 |
D/D |
30,919 |
30,919 |
0 |
- |
|
| CYCC |
Cyclacel Pharmaceuticals ... |
Director |
– • – |
2022-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
15,822 |
19,383 |
0 |
- |
|
| CYCC |
Cyclacel Pharmaceuticals ... |
Director |
– • – |
2021-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
3,561 |
3,561 |
0 |
- |
|
| VINC |
Vincerx Pharma, Inc |
Director |
– • – |
2020-03-05 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
6,000 |
|
- |
|
| ARQL |
Arqule Inc |
See Remarks |
• – – |
2020-01-16 |
4 |
D |
$20.00 |
$5,796,760 |
D/D |
(289,838) |
0 |
0 |
- |
|
| ARQL |
Arqule Inc |
Chief Medical Officer |
• – – |
2019-12-18 |
4 |
D |
$20.11 |
$3,589,534 |
D/D |
(178,495) |
289,838 |
0 |
- |
|
| ARQL |
Arqule Inc |
Chief Medical Officer |
• – – |
2019-12-18 |
4 |
OE |
$1.79 |
$1,418,281 |
D/D |
351,046 |
468,333 |
0 |
- |
|
| ARQL |
Arqule Inc |
Chief Medical Officer |
• – – |
2018-06-13 |
4 |
D |
$5.18 |
$769,587 |
D/D |
(148,569) |
97,169 |
0 |
- |
|
| ARQL |
Arqule Inc |
Chief Medical Officer |
• – – |
2018-06-13 |
4 |
OE |
$3.62 |
$724,000 |
D/D |
200,000 |
245,738 |
0 |
- |
|
| ARQL |
Arqule Inc |
Chief Medical Officer |
• – – |
2017-01-14 |
4 |
D |
$1.58 |
$4,498 |
D/D |
(2,847) |
45,738 |
0 |
- |
|
| ARQL |
Arqule Inc |
Chief Medical Officer |
• – – |
2016-01-14 |
4 |
D |
$1.86 |
$5,295 |
D/D |
(2,847) |
48,585 |
0 |
- |
|
| ARQL |
Arqule Inc |
Chief Medical Officer |
• – – |
2015-01-14 |
4 |
D |
$1.20 |
$3,416 |
D/D |
(2,847) |
51,432 |
0 |
- |
|
| ARQL |
Arqule Inc |
Chief Medical Officer |
• – – |
2014-01-14 |
4 |
D |
$2.36 |
$6,719 |
D/D |
(2,847) |
54,279 |
0 |
- |
|
| ARQL |
Arqule Inc |
Chief Medical Officer |
• – – |
2013-01-18 |
4 |
D |
$2.54 |
$2,822 |
D/D |
(1,111) |
57,126 |
0 |
- |
|
| ARQL |
Arqule Inc |
Chief Scientific Officer |
• – – |
2013-01-14 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
58,237 |
0 |
- |
|
| ARQL |
Arqule Inc |
Chief Medical Officer |
• – – |
2012-06-06 |
4 |
B |
$6.26 |
$29,412 |
D/D |
4,700 |
28,237 |
2.74 |
- |
|
| ARQL |
Arqule Inc |
Chief Medical Officer |
• – – |
2012-01-20 |
4 |
D |
$7.02 |
$7,385 |
D/D |
(1,052) |
23,537 |
0 |
- |
|
| ARQL |
Arqule Inc |
Chief Medical Officer |
• – – |
2011-08-31 |
4 |
B |
$4.41 |
$17,621 |
D/D |
4,000 |
24,589 |
2.74 |
- |
|
| ARQL |
Arqule Inc |
Chief Medical Officer |
• – – |
2010-01-20 |
4 |
A |
$3.53 |
$3,922 |
D/D |
1,111 |
20,589 |
0 |
- |
|
| ARQL |
Arqule Inc |
Chief Medical Officer |
• – – |
2009-01-20 |
4 |
A |
$0.00 |
$0 |
D/D |
11,700 |
21,700 |
0 |
- |
|
| ARQL |
Arqule Inc |
Chief Medical Officer |
• – – |
2008-12-05 |
4 |
B |
$3.39 |
$33,947 |
D/D |
10,000 |
10,000 |
2.74 |
- |
|
| TCRT |
Alaunos Therapeutics |
V.P. Chief Medical OfficerOffi |
• – – |
2008-03-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
25,000 |
|
- |
|
24 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
